Urological Devices Market Report Suite | United States | 2019-2025| MedSuite (Includes 10 Reports)

Table of Content

TABLE OF CONTENTS I
List of Figures XV
LIST OF CHARTS XXIX
EXECUTIVE SUMMARY 1
U.S. UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE CODES INVESTIGATED 9
PROCEDURE NUMBERS 10
MARKETS INCLUDED 12
KEY REPORT UPDATES 18
VERSION HISTORY 18
RESEARCH METHODOLOGY 19
Step 1: Project Initiation & Team Selection 19
Step 2: Prepare Data Systems and Perform Secondary Research 22
Step 3: Preparation for Interviews & Questionnaire Design 24
Step 4: Performing Primary Research 25
Step 5: Research Analysis: Establishing Baseline Estimates 27
Step 6: Market Forecast and Analysis 28
Step 7: Identify Strategic Opportunities 30
Step 8: Final Review and Market Release 31
Step 9: Customer Feedback and Market Monitoring 32
?
DISEASE OVERVIEW 33
2.1 BASIC ANATOMY 33
2.1.1 Urinary System 33
2.1.1.1 Male Urinary System 34
2.1.1.2 Female Urinary System 35
2.2 DISEASE TREATMENT AND DIAGNOSTICS 36
2.2.1 Benign Prostatic Hyperplasia 36
2.2.2 Urinary Incontinence 37
2.2.3 Urinary Tract Infections 39
2.2.4 Kidney Stones 40
2.2.5 Bladder Prolapse 42
2.2.6 Overactive Bladder 43
2.2.7 Prostatitis 44
2.2.8 Erectile Dysfunction 46
2.2.9 Cancer 47
2.2.9.1 Prostate Cancer 47
2.2.9.2 Bladder Cancer 48
2.3 PATIENT DEMOGRAPHICS 50
2.3.1 Benign Prostatic Hyperplasia 50
2.3.2 Urinary Incontinence 50
2.3.3 Urinary Tract Infections 51
2.3.4 Kidney Stones 52
2.3.5 Bladder Prolapse 52
2.3.6 Overactive Bladder 53
2.3.7 Prostatitis 54
2.3.8 Erectile Dysfunction 54
2.3.9 Cancer 55
2.3.9.1 Prostate Cancer 55
2.3.9.2 Bladder Cancer 56
?
PRODUCT ASSESSMENT 57
3.1 INTRODUCTION 57
3.2 PRODUCT PORTFOLIOS 57

U.S. UROLOGICAL DEVICE MARKET OVERVIEW 153
4.1 MARKET OVERVIEW 153
4.2 TREND ANALYSIS BY SEGMENT 160
4.3 DRIVERS AND LIMITERS 164
4.3.1 Market Drivers 164
4.3.2 Market Limiters 164
4.4 COMPETITIVE MARKET SHARE ANALYSIS 166
4.5 MERGERS AND ACQUISITIONS 171
4.6 COMPANY PROFILES 172
4.6.1 Boston Scientific 172
4.6.2 C. R. Bard (Becton Dickinson) 174
4.6.3 Coloplast 176
4.6.4 Cook Medical 177
4.6.5 Elekta 178
4.6.6 Ethicon 179
4.6.7 Karl Storz 180
4.6.8 Laborie 181
4.6.9 Medline 182
4.6.10 Olympus 184
4.7 SWOT ANALYSIS 186
4.7.1 Boston Scientific 187
4.7.2 C. R. Bard (Becton Dickinson) 189
4.7.3 Coloplast 191
4.7.4 Cook Medical 192
4.7.5 Elekta 194
4.7.6 Ethicon 195
4.7.7 Karl Storz 196
4.7.8 Laborie 197
4.7.9 Medline 198
4.7.10 Olympus 200
PROCEDURE NUMBERS 202
5.1 PROCEDURE CODES INVESTIGATED 202
5.2 PROCEDURE OVERVIEW 203
5.3 URINARY INCONTINENCE PROCEDURES 206
5.3.1 Male Incontinence Management Procedures 208
5.3.2 Female Incontinence Management Procedures 210
5.4 STONE MANAGEMENT PROCEDURES 213
5.4.1 ESWL Procedures 215
5.4.2 Transurethral Procedures 217
5.4.3 Ureteral Stent Placement Procedures 219
5.4.4 PCNL Procedures 221
5.5 BPH PROCEDURES 223
5.5.1 BPH Patient Statistics 223
5.5.2 BPH Procedures 225
5.6 PROSTATE CANCER TREATMENT PROCEDURES 228
5.6.1 Prostate Cancer Statistics 228
5.6.2 Prostate Cancer Treatment Procedures 229
5.6.2.1 Watchful Waiting 231
5.6.2.2 Prostatectomy Procedures 233
5.6.2.2.1 Open Prostatectomy Procedures 235
5.6.2.3 Ablation Procedures 238
5.6.2.4 Radiation Therapy Procedures 240
5.6.2.4.1 Prostate HDR Brachytherapy Procedures 242
5.6.2.4.2 Prostate LDR Brachytherapy Procedures 244
5.6.2.4.3 Prostate External Radiation Therapy Procedures 246
5.7 URODYNAMIC TESTING PROCEDURES 248
5.7.1 Cystometrogram Procedures 250
5.7.2 Uroflowmetry Procedures 252
5.8 NEPHROSTOMY PROCEDURES 254
5.9 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 256
URINARY INCONTINENCE DEVICE MARKET 258
6.1 INTRODUCTION 258
6.2 MARKET OVERVIEW 260
6.3 MARKET ANALYSIS AND FORECAST 265
6.3.1 Total Urinary Catheter Market 265
6.3.1.1 Total Intermittent Catheter Market 267
6.3.1.1.1 Coated Intermittent Catheter Market 271
6.3.1.1.2 Total Uncoated Intermittent Catheter Market 273
6.3.1.1.3 Total Closed System Intermittent Catheter Market 281
6.3.1.2 Total Foley Catheter Market 289
6.3.1.2.1 Coated Latex Foley Catheter Market 293
6.3.1.2.2 Total Latex-Free Foley Catheter Market 295
6.3.1.2.3 Total Closed System Foley Catheter Market 303
6.3.1.3 Male External Catheter Market 311
6.3.2 Total Urethral Bulking Agent Market 313
6.3.2.1 Male Urethral Bulking Agent Market 317
6.3.2.2 Female Urethral Bulking Agent Market 319
6.3.3 Total Incontinence Management Device Market 321
6.3.3.1 Total Female Incontinence Sling Market 323
6.3.3.2 Total Male Implantable Incontinence Device Market 334
6.3.3.2.1 Male Incontinence Sling Market 336
6.3.3.2.2 Male Artificial Urinary Sphincter Market 338
6.3.4 Total Urinary Bag Market 340
6.3.4.1 Bedside Urine Drainage Bag Market 344
6.3.4.2 Leg Urine Drainage Bag Market 346
6.4 DRIVERS AND LIMITERS 348
6.4.1 Market Drivers 348
6.4.2 Market Limiters 349
6.5 COMPETITIVE MARKET SHARE ANALYSIS 351
6.5.1 Urinary Incontinence Device Market 351
6.5.2 Urinary Catheter Market 354
6.5.3 Incontinence Management Device Market 356
6.5.4 Male Implantable Incontinence Device Market 358
STONE MANAGEMENT DEVICE MARKET 360
7.1 INTRODUCTION 360
7.2 MARKET OVERVIEW 362
7.3 MARKET ANALYSIS AND FORECAST 367
7.3.1 ESWL Equipment Market 367
7.3.2 ISWL Equipment Market 370
7.3.3 Total Holmium Laser Market 373
7.3.3.1 Total Holmium Laser Equipment Market 375
7.3.3.1.1 High Power Holmium Laser Equipment Market 379
7.3.3.1.2 Low Power Holmium Laser Equipment Market 381
7.3.3.2 Total Holmium Laser Fiber Market 383
7.3.3.2.1 Reusable Holmium Laser Fiber Market 388
7.3.3.2.2 Single-Use Holmium Laser Fiber Market 390
7.3.4 Total Stone Fragment Retrieval Device Market 392
7.3.4.1 Nitinol Stone Fragment Retrieval Device Market 397
7.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 399
7.3.5 Ureteral Stent Market 401
7.4 DRIVERS AND LIMITERS 408
7.4.1 Market Drivers 408
7.4.2 Market Limiters 409
7.5 COMPETITIVE MARKET SHARE ANALYSIS 411
BPH TREATMENT DEVICE MARKET 417
8.1 INTRODUCTION 417
8.1.1 Treatments 417
8.1.1.1 TURP 418
8.1.1.2 Minimally Invasive Treatments 418
8.1.1.3 Laser BPH Treatments 419
8.1.1.3.1 Photoselective Vaporization of the Prostate (PVP) 419
8.1.1.3.2 Laser Vaporization of the Prostate 420
8.1.1.3.3 Laser Ablation of the Prostate 420
8.1.1.3.4 Laser Resection of the Prostate 421
8.1.1.3.5 Laser Enucleation of the Prostate 421
8.1.2 Comparison of TURP and Laser BPH Procedures 422
8.1.3 Emerging Technologies 422
8.2 MARKET OVERVIEW 424
8.3 MARKET ANALYSIS AND FORECAST 429
8.3.1 Total TURP Market 429
8.3.1.1 Total Monopolar Electrode Market 431
8.3.1.1.1 Monopolar Electrode Loop Market 435
8.3.1.1.2 Monopolar Coagulating Resector Electrode Market 437
8.3.1.1.3 Monopolar Vaporizing Electrode Market 439
8.3.1.1.4 Other Monopolar Electrode Device Market 441
8.3.1.2 Total Bipolar Electrode Market 443
8.3.1.2.1 Bipolar Electrode Loop Market 447
8.3.1.2.2 Bipolar Vaporizing Electrode Market 449
8.3.1.2.3 Other Bipolar Electrode Device Market 451
8.3.2 Total TUMT Market 453
8.3.2.1 TUMT Equipment Market 455
8.3.2.2 TUMT Consumables Market 457
8.3.3 Total TUNA Market 459
8.3.3.1 TUNA Equipment Market 461
8.3.3.2 TUNA Consumables Market 463
8.3.4 Total Prostatic Stent Market 465
8.3.4.1 Permanent Prostatic Stent Market 469
8.3.4.2 Temporary Prostatic Stent Market 471
8.3.5 Total Laser BPH Market 473
8.3.5.1 Laser BPH Equipment Market 475
8.3.5.2 Total Laser BPH Fiber Market 477
8.3.5.2.1 PVP Laser Fiber Market 482
8.3.5.2.2 Laser Enucleation Fiber Market 484
8.3.5.2.3 Other Laser BPH Fiber Market 486
8.3.6 UroLift Market 488
8.3.7 Rez?m Market 490
8.4 DRIVERS AND LIMITERS 492
8.4.1 Market Drivers 492
8.4.2 Market Limiters 493
8.5 COMPETITIVE MARKET SHARE ANALYSIS 496
8.5.1 BPH Treatment Device Market 496
8.5.2 TURP Market 500
UROLOGICAL ENDOSCOPE MARKET 502
9.1 INTRODUCTION 502
9.2 MARKET OVERVIEW 504
9.2.1 Urological Endoscope Market by Segment 504
9.2.2 Urological Endoscope Market by Condition 509
9.3 MARKET ANALYSIS AND FORECAST 513
9.3.1 Total Urological Endoscope Market 513
9.3.2 Total Cystoscope Market 516
9.3.2.1 Total Rigid Cystoscope Market 520
9.3.2.1.1 New Rigid Cystoscope Market 525
9.3.2.1.2 Refurbished Rigid Cystoscope Market 527
9.3.2.2 Total Flexible Cystoscope Market 529
9.3.2.2.1 Total New Flexible Cystoscope Market 533
9.3.2.2.2 Total Refurbished Flexible Cystoscope Market 542
9.3.3 Total Ureteroscope Market 550
9.3.3.1 Total Semi-Rigid Ureteroscope Market 554
9.3.3.1.1 New Semi-Rigid Ureteroscope Market 559
9.3.3.1.2 Refurbished Semi-Rigid Ureteroscope Market 561
9.3.3.2 Total Flexible Ureteroscope Market 563
9.3.3.2.1 Total New Flexible Ureteroscope Market 567
9.3.3.2.2 Total Refurbished Flexible Ureteroscope Market 577
9.3.4 Total Resectoscope Market 585
9.3.4.1 New Resectoscope Market 589
9.3.4.2 Refurbished Resectoscope Market 591
9.3.5 Total Nephroscope Market 593
9.3.5.1 New Nephroscope Market 597
9.3.5.2 Refurbished Nephroscope Market 599
9.4 DRIVERS AND LIMITERS 601
9.4.1 Market Drivers 601
9.4.2 Market Limiters 602
9.5 COMPETITIVE MARKET SHARE ANALYSIS 604
9.5.1 Urological Endoscope Market 604
9.5.2 Cystoscope Market 608
TABLE OF CONTENTS I
List of Figures XV
LIST OF CHARTS XXIX
EXECUTIVE SUMMARY 1
U.S. UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE CODES INVESTIGATED 9
PROCEDURE NUMBERS 10
MARKETS INCLUDED 12
KEY REPORT UPDATES 18
VERSION HISTORY 18
RESEARCH METHODOLOGY 19
Step 1: Project Initiation & Team Selection 19
Step 2: Prepare Data Systems and Perform Secondary Research 22
Step 3: Preparation for Interviews & Questionnaire Design 24
Step 4: Performing Primary Research 25
Step 5: Research Analysis: Establishing Baseline Estimates 27
Step 6: Market Forecast and Analysis 28
Step 7: Identify Strategic Opportunities 30
Step 8: Final Review and Market Release 31
Step 9: Customer Feedback and Market Monitoring 32
?
DISEASE OVERVIEW 33
2.1 BASIC ANATOMY 33
2.1.1 Urinary System 33
2.1.1.1 Male Urinary System 34
2.1.1.2 Female Urinary System 35
2.2 DISEASE TREATMENT AND DIAGNOSTICS 36
2.2.1 Benign Prostatic Hyperplasia 36
2.2.2 Urinary Incontinence 37
2.2.3 Urinary Tract Infections 39
2.2.4 Kidney Stones 40
2.2.5 Bladder Prolapse 42
2.2.6 Overactive Bladder 43
2.2.7 Prostatitis 44
2.2.8 Erectile Dysfunction 46
2.2.9 Cancer 47
2.2.9.1 Prostate Cancer 47
2.2.9.2 Bladder Cancer 48
2.3 PATIENT DEMOGRAPHICS 50
2.3.1 Benign Prostatic Hyperplasia 50
2.3.2 Urinary Incontinence 50
2.3.3 Urinary Tract Infections 51
2.3.4 Kidney Stones 52
2.3.5 Bladder Prolapse 52
2.3.6 Overactive Bladder 53
2.3.7 Prostatitis 54
2.3.8 Erectile Dysfunction 54
2.3.9 Cancer 55
2.3.9.1 Prostate Cancer 55
2.3.9.2 Bladder Cancer 56
?
PRODUCT ASSESSMENT 57
3.1 INTRODUCTION 57
3.2 PRODUCT PORTFOLIOS 57
3.2.1 Urinary Incontinence 57
3.2.1.1 Urinary Catheters 57
3.2.1.1.1 Intermittent Catheters 57
3.2.1.1.2 Foley Catheters 58
3.2.1.1.3 Male External Catheters 59
3.2.1.2 Urethral Bulking Agents 60
3.2.1.3 Incontinence Management Devices 61
3.2.1.3.1 Female Incontinence Slings 61
3.2.1.3.2 Male Implantable Devices 61
3.2.1.4 Urine Bags 63
3.2.1.4.1 Leg Bags 63
3.2.1.4.2 Night Bags 64
3.2.2 Stone Management 68
3.2.2.1 ESWL Equipment 68
3.2.2.2 ISWL Equipment 69
3.2.2.3 Holmium Lasers 69
3.2.2.4 Stone Fragment Retrieval Devices 70
3.2.2.5 Ureteral Stents 70
3.2.3 BPH Treatment 74
3.2.3.1 TURP 74
3.2.3.2 TUMT 75
3.2.3.3 TUNA 75
3.2.3.4 Prostatic Stents 76
3.2.3.5 Laser BPH 77
3.2.3.5.1 Photoselective Vaporization of the Prostate (PVP) 78
3.2.3.5.2 Laser Vaporization of the Prostate 79
3.2.3.5.3 Laser Ablation of the Prostate 79
3.2.3.5.4 Laser Resection of the Prostate 80
3.2.3.5.5 Laser Enucleation of the Prostate 81
3.2.4 Urological Endoscopes 83
3.2.4.1 Cystoscopes 83
3.2.4.2 Ureteroscopes 84
3.2.4.3 Resectoscopes 85
3.2.4.4 Nephroscopes 85
3.2.5 Prostate Cancer Treatment 89
3.2.5.1 Brachytherapy 89
3.2.5.1.1 Permanent Implants 89
3.2.5.1.2 Temporary Implants 89
3.2.5.2 Cryotherapy 91
3.2.6 Urodynamics 93
3.2.6.1 Urodynamic Equipment 93
3.2.6.2 Urodynamic Consumables 94
3.2.6.2.1 Water-charged Catheters 94
3.2.6.2.2 Air-charged Catheters 95
3.2.6.2.3 Fiber Optic Catheters 95
3.2.7 Nephrostomy 97
3.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets 97
3.2.7.2 Nephrostomy Balloon Catheters 98
3.2.7.3 Ureteral Stents 98
3.2.8 Erectile Dysfunction 102
3.2.8.1 Penile Implants 102
3.2.8.1.1 Inflatable 102
3.2.8.1.2 Malleable 103
3.2.8.2 Vacuum 103
3.3 REGULATORY ISSUES AND RECALLS 105
3.3.1 Boston Scientific 105
3.3.1.1 Stone Management 105
3.3.1.2 Nephrostomy 107
3.3.2 C. R. Bard (Becton Dickinson) 108
3.3.2.1 Urinary Incontinence 108
3.3.2.2 Stone Management 113
3.3.2.3 Urological Endoscopes 113
3.3.2.4 Prostate Cancer Treatment 113
3.3.2.5 Nephrostomy 114
3.3.3 Coloplast 116
3.3.3.1 Urinary Catheter 116
3.3.3.2 Erectile Dysfunction 116
3.3.4 Cook Medical 117
3.3.4.1 Stone Management 117
3.3.4.2 Nephrostomy 118
3.3.5 Elekta 120
3.3.5.1 Prostate Cancer Treatment 120
3.3.6 Karl Storz 121
3.3.6.1 Urological Endoscopes 121
3.3.7 Olympus 122
3.3.7.1 Urological Endoscopes 122
3.4 CLINICAL TRIALS 124
3.4.1 Boston Scientific 124
3.4.1.1 Urinary Incontinence 124
3.4.1.2 BPH Treatment 125
3.4.1.3 Urological endoscopes 126
3.4.1.4 Nephrostomy 127
3.4.1.5 Erectile Dysfunction 128
3.4.2 C. R. Bard (Becton Dickinson) 129
3.4.2.1 Urinary Incontinence 129
3.4.2.2 Prostate Cancer Treatment 131
3.4.3 Coloplast 132
3.4.3.1 Urinary Incontinence 132
3.4.4 Cook Medical 135
3.4.4.1 Nephrostomy 135
3.4.5 Elekta 137
3.4.5.1 Prostate Cancer Treatment 137
3.4.6 Ethicon 139
3.4.6.1 Urinary Incontinence 139
3.4.7 Karl Storz 141
3.4.7.1 Stone Management 141
3.4.7.2 Urological Endoscopes 143
3.4.8 Laborie 146
3.4.8.1 Urodynamics 146
3.4.9 Medline 148
3.4.9.1 Urinary Incontinence 148
3.4.10 Olympus 149
3.4.10.1 Stone Management 149
3.4.10.2 BPH Treatment 150
3.4.10.3 Urological Endoscopes 151
U.S. UROLOGICAL DEVICE MARKET OVERVIEW 153
4.1 MARKET OVERVIEW 153
4.2 TREND ANALYSIS BY SEGMENT 160
4.3 DRIVERS AND LIMITERS 164
4.3.1 Market Drivers 164
4.3.2 Market Limiters 164
4.4 COMPETITIVE MARKET SHARE ANALYSIS 166
4.5 MERGERS AND ACQUISITIONS 171
4.6 COMPANY PROFILES 172
4.6.1 Boston Scientific 172
4.6.2 C. R. Bard (Becton Dickinson) 174
4.6.3 Coloplast 176
4.6.4 Cook Medical 177
4.6.5 Elekta 178
4.6.6 Ethicon 179
4.6.7 Karl Storz 180
4.6.8 Laborie 181
4.6.9 Medline 182
4.6.10 Olympus 184
4.7 SWOT ANALYSIS 186
4.7.1 Boston Scientific 187
4.7.2 C. R. Bard (Becton Dickinson) 189
4.7.3 Coloplast 191
4.7.4 Cook Medical 192
4.7.5 Elekta 194
4.7.6 Ethicon 195
4.7.7 Karl Storz 196
4.7.8 Laborie 197
4.7.9 Medline 198
4.7.10 Olympus 200
PROCEDURE NUMBERS 202
5.1 PROCEDURE CODES INVESTIGATED 202
5.2 PROCEDURE OVERVIEW 203
5.3 URINARY INCONTINENCE PROCEDURES 206
5.3.1 Male Incontinence Management Procedures 208
5.3.2 Female Incontinence Management Procedures 210
5.4 STONE MANAGEMENT PROCEDURES 213
5.4.1 ESWL Procedures 215
5.4.2 Transurethral Procedures 217
5.4.3 Ureteral Stent Placement Procedures 219
5.4.4 PCNL Procedures 221
5.5 BPH PROCEDURES 223
5.5.1 BPH Patient Statistics 223
5.5.2 BPH Procedures 225
5.6 PROSTATE CANCER TREATMENT PROCEDURES 228
5.6.1 Prostate Cancer Statistics 228
5.6.2 Prostate Cancer Treatment Procedures 229
5.6.2.1 Watchful Waiting 231
5.6.2.2 Prostatectomy Procedures 233
5.6.2.2.1 Open Prostatectomy Procedures 235
5.6.2.3 Ablation Procedures 238
5.6.2.4 Radiation Therapy Procedures 240
5.6.2.4.1 Prostate HDR Brachytherapy Procedures 242
5.6.2.4.2 Prostate LDR Brachytherapy Procedures 244
5.6.2.4.3 Prostate External Radiation Therapy Procedures 246
5.7 URODYNAMIC TESTING PROCEDURES 248
5.7.1 Cystometrogram Procedures 250
5.7.2 Uroflowmetry Procedures 252
5.8 NEPHROSTOMY PROCEDURES 254
5.9 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 256
URINARY INCONTINENCE DEVICE MARKET 258
6.1 INTRODUCTION 258
6.2 MARKET OVERVIEW 260
6.3 MARKET ANALYSIS AND FORECAST 265
6.3.1 Total Urinary Catheter Market 265
6.3.1.1 Total Intermittent Catheter Market 267
6.3.1.1.1 Coated Intermittent Catheter Market 271
6.3.1.1.2 Total Uncoated Intermittent Catheter Market 273
6.3.1.1.3 Total Closed System Intermittent Catheter Market 281
6.3.1.2 Total Foley Catheter Market 289
6.3.1.2.1 Coated Latex Foley Catheter Market 293
6.3.1.2.2 Total Latex-Free Foley Catheter Market 295
6.3.1.2.3 Total Closed System Foley Catheter Market 303
6.3.1.3 Male External Catheter Market 311
6.3.2 Total Urethral Bulking Agent Market 313
6.3.2.1 Male Urethral Bulking Agent Market 317
6.3.2.2 Female Urethral Bulking Agent Market 319
6.3.3 Total Incontinence Management Device Market 321
6.3.3.1 Total Female Incontinence Sling Market 323
6.3.3.2 Total Male Implantable Incontinence Device Market 334
6.3.3.2.1 Male Incontinence Sling Market 336
6.3.3.2.2 Male Artificial Urinary Sphincter Market 338
6.3.4 Total Urinary Bag Market 340
6.3.4.1 Bedside Urine Drainage Bag Market 344
6.3.4.2 Leg Urine Drainage Bag Market 346
6.4 DRIVERS AND LIMITERS 348
6.4.1 Market Drivers 348
6.4.2 Market Limiters 349
6.5 COMPETITIVE MARKET SHARE ANALYSIS 351
6.5.1 Urinary Incontinence Device Market 351
6.5.2 Urinary Catheter Market 354
6.5.3 Incontinence Management Device Market 356
6.5.4 Male Implantable Incontinence Device Market 358
STONE MANAGEMENT DEVICE MARKET 360
7.1 INTRODUCTION 360
7.2 MARKET OVERVIEW 362
7.3 MARKET ANALYSIS AND FORECAST 367
7.3.1 ESWL Equipment Market 367
7.3.2 ISWL Equipment Market 370
7.3.3 Total Holmium Laser Market 373
7.3.3.1 Total Holmium Laser Equipment Market 375
7.3.3.1.1 High Power Holmium Laser Equipment Market 379
7.3.3.1.2 Low Power Holmium Laser Equipment Market 381
7.3.3.2 Total Holmium Laser Fiber Market 383
7.3.3.2.1 Reusable Holmium Laser Fiber Market 388
7.3.3.2.2 Single-Use Holmium Laser Fiber Market 390
7.3.4 Total Stone Fragment Retrieval Device Market 392
7.3.4.1 Nitinol Stone Fragment Retrieval Device Market 397
7.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 399
7.3.5 Ureteral Stent Market 401
7.4 DRIVERS AND LIMITERS 408
7.4.1 Market Drivers 408
7.4.2 Market Limiters 409
7.5 COMPETITIVE MARKET SHARE ANALYSIS 411
BPH TREATMENT DEVICE MARKET 417
8.1 INTRODUCTION 417
8.1.1 Treatments 417
8.1.1.1 TURP 418
8.1.1.2 Minimally Invasive Treatments 418
8.1.1.3 Laser BPH Treatments 419
8.1.1.3.1 Photoselective Vaporization of the Prostate (PVP) 419
8.1.1.3.2 Laser Vaporization of the Prostate 420
8.1.1.3.3 Laser Ablation of the Prostate 420
8.1.1.3.4 Laser Resection of the Prostate 421
8.1.1.3.5 Laser Enucleation of the Prostate 421
8.1.2 Comparison of TURP and Laser BPH Procedures 422
8.1.3 Emerging Technologies 422
8.2 MARKET OVERVIEW 424
8.3 MARKET ANALYSIS AND FORECAST 429
8.3.1 Total TURP Market 429
8.3.1.1 Total Monopolar Electrode Market 431
8.3.1.1.1 Monopolar Electrode Loop Market 435
8.3.1.1.2 Monopolar Coagulating Resector Electrode Market 437
8.3.1.1.3 Monopolar Vaporizing Electrode Market 439
8.3.1.1.4 Other Monopolar Electrode Device Market 441
8.3.1.2 Total Bipolar Electrode Market 443
8.3.1.2.1 Bipolar Electrode Loop Market 447
8.3.1.2.2 Bipolar Vaporizing Electrode Market 449
8.3.1.2.3 Other Bipolar Electrode Device Market 451
8.3.2 Total TUMT Market 453
8.3.2.1 TUMT Equipment Market 455
8.3.2.2 TUMT Consumables Market 457
8.3.3 Total TUNA Market 459
8.3.3.1 TUNA Equipment Market 461
8.3.3.2 TUNA Consumables Market 463
8.3.4 Total Prostatic Stent Market 465
8.3.4.1 Permanent Prostatic Stent Market 469
8.3.4.2 Temporary Prostatic Stent Market 471
8.3.5 Total Laser BPH Market 473
8.3.5.1 Laser BPH Equipment Market 475
8.3.5.2 Total Laser BPH Fiber Market 477
8.3.5.2.1 PVP Laser Fiber Market 482
8.3.5.2.2 Laser Enucleation Fiber Market 484
8.3.5.2.3 Other Laser BPH Fiber Market 486
8.3.6 UroLift Market 488
8.3.7 Rez?m Market 490
8.4 DRIVERS AND LIMITERS 492
8.4.1 Market Drivers 492
8.4.2 Market Limiters 493
8.5 COMPETITIVE MARKET SHARE ANALYSIS 496
8.5.1 BPH Treatment Device Market 496
8.5.2 TURP Market 500
UROLOGICAL ENDOSCOPE MARKET 502
9.1 INTRODUCTION 502
9.2 MARKET OVERVIEW 504
9.2.1 Urological Endoscope Market by Segment 504
9.2.2 Urological Endoscope Market by Condition 509
9.3 MARKET ANALYSIS AND FORECAST 513
9.3.1 Total Urological Endoscope Market 513
9.3.2 Total Cystoscope Market 516
9.3.2.1 Total Rigid Cystoscope Market 520
9.3.2.1.1 New Rigid Cystoscope Market 525
9.3.2.1.2 Refurbished Rigid Cystoscope Market 527
9.3.2.2 Total Flexible Cystoscope Market 529
9.3.2.2.1 Total New Flexible Cystoscope Market 533
9.3.2.2.2 Total Refurbished Flexible Cystoscope Market 542
9.3.3 Total Ureteroscope Market 550
9.3.3.1 Total Semi-Rigid Ureteroscope Market 554
9.3.3.1.1 New Semi-Rigid Ureteroscope Market 559
9.3.3.1.2 Refurbished Semi-Rigid Ureteroscope Market 561
9.3.3.2 Total Flexible Ureteroscope Market 563
9.3.3.2.1 Total New Flexible Ureteroscope Market 567
9.3.3.2.2 Total Refurbished Flexible Ureteroscope Market 577
9.3.4 Total Resectoscope Market 585
9.3.4.1 New Resectoscope Market 589
9.3.4.2 Refurbished Resectoscope Market 591
9.3.5 Total Nephroscope Market 593
9.3.5.1 New Nephroscope Market 597
9.3.5.2 Refurbished Nephroscope Market 599
9.4 DRIVERS AND LIMITERS 601
9.4.1 Market Drivers 601
9.4.2 Market Limiters 602
9.5 COMPETITIVE MARKET SHARE ANALYSIS 604
9.5.1 Urological Endoscope Market 604
9.5.2 Cystoscope Market 608
9.5.3 Ureteroscope Market 610
9.5.4 Flexible Ureteroscope Market 612
PROSTATE CANCER TREATMENT DEVICE MARKET 614
10.1 INTRODUCTION 614
10.2 MARKET OVERVIEW 616
10.3 MARKET ANALYSIS AND FORECAST 620
10.3.1 Total Brachytherapy Device Market 620
10.3.1.1 Total HDR Brachytherapy Market 622
10.3.1.1.1 Afterloader Market 624
10.3.1.1.2 Afterloader Service Market 626
10.3.1.2 Total LDR Brachytherapy Market 628
10.3.1.2.1 Total LDR Seed Market 630
10.3.1.2.2 LDR Needle Market 660
10.3.2 Total Cryotherapy Ablation Device Market 662
10.3.2.1 Cryotherapy Ablation Device Market 665
10.3.2.2 Cryotherapy Ablation Device Rental Market 667
10.3.2.3 Cryotherapy Ablation Probe Market 669
10.4 DRIVERS AND LIMITERS 671
10.4.1 Market Drivers 671
10.4.2 Market Limiters 672
10.5 COMPETITIVE MARKET SHARE ANALYSIS 673
10.5.1 Prostate Cancer Treatment Device Market 673
10.5.2 Brachytherapy Device Market 677
URODYNAMIC EQUIPMENT MARKET 679
11.1 INTRODUCTION 679
11.2 MARKET OVERVIEW 680
11.3 MARKET ANALYSIS AND FORECAST 685
11.3.1 Total Urodynamic Equipment Market 685
11.3.1.1 Hospital Urodynamic Capital Equipment Market 689
11.3.1.2 Medical Office Urodynamic Capital Equipment Market 692
11.3.2 Total Urodynamic Consumables Market 694
11.3.2.1 Air-Charged Catheter Market 698
11.3.2.2 Water-Filled Catheter Market 701
11.3.2.3 Fiber Optic Catheter Market 704
11.4 DRIVERS AND LIMITERS 707
11.4.1 Market Drivers 707
11.4.2 Market Limiters 708
11.5 COMPETITIVE MARKET SHARE ANALYSIS 709
NEPHROSTOMY DEVICE MARKET 713
12.1 INTRODUCTION 713
12.2 MARKET OVERVIEW 715
12.3 MARKET ANALYSIS AND FORECAST 720
12.3.1 Percutaneous Nephrostomy Set Market 720
12.3.2 Nephrostomy Balloon Catheter Market 723
12.3.3 Nephrostomy Drainage Tube Market 725
12.4 DRIVERS AND LIMITERS 727
12.4.1 Market Drivers 727
12.4.2 Market Limiters 727
12.5 COMPETITIVE MARKET SHARE ANALYSIS 729
ERECTILE DYSFUNCTION DEVICE MARKET 733
13.1 INTRODUCTION 733
13.1.1 Low Testosterone Pharmaceutical Delivery 734
13.2 MARKET OVERVIEW 735
13.3 MARKET ANALYSIS AND FORECAST 739
13.3.1 Inflatable Erectile Dysfunction Device Market 739
13.3.2 Malleable Erectile Dysfunction Device Market 742
13.3.3 Vacuum Erection Device Market 744
13.4 DRIVERS AND LIMITERS 746
13.4.1 Market Drivers 746
13.4.2 Market Limiters 747
13.5 COMPETITIVE MARKET SHARE ANALYSIS 748
ABBREVIATIONS 751

List of Figures

Figure 1 1: Urological Device Market Share Ranking by Segment, U.S., 2018 (1 of 2) 3
Figure 1 2: Urological Device Market Share Ranking by Segment, U.S., 2018 (2 of 2) 3
Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 2) 4
Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 2) 5
Figure 1 5: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2) 6
Figure 1 6: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2) 7
Figure 1 7: Recent Events in the Urological Device Market, U.S., 2015 – 2018 8
Figure 1 8: Procedure Codes Investigated, U.S., 2018 9
Figure 1 9: Urological Procedures Covered, U.S., 2018 (1 of 2) 10
Figure 1 10: Urological Procedures Covered, U.S., 2018 (2 of 2) 11
Figure 1 11: Urological Device Markets Covered, U.S., 2018 (1 of 6) 12
Figure 1 12: Urological Device Markets Covered, U.S., 2018 (2 of 6) 13
Figure 1 13: Urological Device Markets Covered, U.S., 2018 (3 of 6) 14
Figure 1 14: Urological Device Markets Covered, U.S., 2018 (4 of 6) 15
Figure 1 15: Urological Device Markets Covered, U.S., 2018 (5 of 6) 16
Figure 1 16: Urological Device Markets Covered, U.S., 2018 (6 of 6) 17
Figure 1 17: Key Report Updates 18
Figure 1 18: Version History 18
Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 65
Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 66
Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 67
Figure 3 4: Stone Management Devices by Company (1 of 3) 71
Figure 3 5: Stone Management Devices by Company (2 of 3) 72
Figure 3 6: Stone Management Devices by Company (3 of 3) 73
Figure 3 7: BPH Treatments by Company 82
Figure 3 8: Urological Endoscopes by Company (1 of 3) 86
Figure 3 9: Urological Endoscopes by Company (2 of 3) 87
Figure 3 10: Urological Endoscopes by Company (3 of 3) 88
Figure 3 11: Prostate Cancer Treatments by Company 92
Figure 3 12: Urodynamic Equipment and Consumables by Company 96
Figure 3 13: Nephrostomy Devices by Company (1 of 3) 99
Figure 3 14: Nephrostomy Devices by Company (2 of 3) 100
Figure 3 15: Nephrostomy Devices by Company (3 of 3) 101
Figure 3 16: Erectile Dysfunction Devices by Company 104
Figure 3 17: Class 2 Device Recall Auriga Laser System 105
Figure 3 18: Class 2 Device Recall Fiber Strippers and Cleavers 106
Figure 3 19: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 107
Figure 3 20: Class 2 Device Recall Malecot Catheter Set 107
Figure 3 21: Class 2 Device Recall Encore(TM) 26 Inflation Device 107
Figure 3 22: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 108
Figure 3 23: Class 2 Device Recall Intermittent Catheters 108
Figure 3 24: Class 2 Device Recall leg bag 108
Figure 3 25: Class 2 Device Recall SURESTEP 109
Figure 3 26: Class 2 Device Recall PureWick External Catheter 109
Figure 3 27: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 109
Figure 3 28: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 110
Figure 3 29: Class 2 Device Recall Magic3 110
Figure 3 30: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 110
Figure 3 31: Class 3 Device Recall SureStep Tray, with AddaFoley 111
Figure 3 32: Class 2 Device Recall BARDEX 111
Figure 3 33: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 111
Figure 3 34: Class 3 Device Recall Antibacterial Hydro Personal Catheter 111
Figure 3 35: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 112
Figure 3 36: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 112
Figure 3 37: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 112
Figure 3 38: Class 2 Device Recall Bard Dimension Stone Basket 113
Figure 3 39: Class 2 Device Recall CMax 113
Figure 3 40: Class 2 Device Recall Bard BrachySource Seed Implants 113
Figure 3 41: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 114
Figure 3 42: Class 2 Device Recall Bard 114
Figure 3 43: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 115
Figure 3 44: Class 2 Device Recall SelfCath Pediatric Catheter 116
Figure 3 45: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 116
Figure 3 46: Class 2 Device Recall Genesis Malleable Penile Prosthesis 116
Figure 3 47: Class 2 Device Recall StoneBreaker 117
Figure 3 48: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 117
Figure 3 49: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 118
Figure 3 50: Class 2 Device Recall Cook Bush 118
Figure 3 51: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 118
Figure 3 52: Class 2 Device Recall Ascend AQ 119
Figure 3 53: Class 2 Device Recall Oncentra Brachy 4.5 120
Figure 3 54: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 120
Figure 3 55: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 120
Figure 3 56: Class 2 Device Recall Oncentra Brachy treatment planning system 120
Figure 3 57: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 121
Figure 3 58: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 121
Figure 3 59: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 122
Figure 3 60: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 122
Figure 3 61: Class 2 Device Recall Olympus High Freqency Resection Electrodes 122
Figure 3 62: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 123
Figure 3 63: Class 2 Device Recall HF Cable WA00014A 123
Figure 3 64: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 124
Figure 3 65: Mid-Urethral Sling Tensioning Trial (MUST) 124
Figure 3 66: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 125
Figure 3 67: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 125
Figure 3 68: LithoVue Single Use Disposable Ureteroscope 126
Figure 3 69: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 126
Figure 3 70: Indwelling Stent Discoloration Project 127
Figure 3 71: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 127
Figure 3 72: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 128
Figure 3 73: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 129
Figure 3 74: Foley Catheter vs a Self-contained Valved Urinary Catheter 129
Figure 3 75: Bladder Morphology Using 2 Different Catheter Designs 130
Figure 3 76: Outpatient Labor Induction With the Transcervical Foley Balloon 130
Figure 3 77: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 131
Figure 3 78: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 131
Figure 3 79: Product Evaluation of a Newly Developed Intermittent Catheter. 132
Figure 3 80: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 132
Figure 3 81: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 132
Figure 3 82: Virtue? European Study 133
Figure 3 83: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 133
Figure 3 84: Altis? 522 Trial - Treatment of Female Stress Urinary Incontinence 133
Figure 3 85: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 134
Figure 3 86: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 134
Figure 3 87: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 134
Figure 3 88: Ureteral Stent Study 135
Figure 3 89: Impact Ureteral Sheath Design During Ureteroscopy 135
Figure 3 90: Optimization of Ureterolysis During Hysterectomy 136
Figure 3 91: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 136
Figure 3 92: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 137
Figure 3 93: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 137
Figure 3 94: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 138
Figure 3 95: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 138
Figure 3 96: Combined Treatment for Mixed Incontinence (ESTEEM) 139
Figure 3 97: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 139
Figure 3 98: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 140
Figure 3 99: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 141
Figure 3 100: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 141
Figure 3 101: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 142
Figure 3 102: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 142
Figure 3 103: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 142
Figure 3 104: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 143
Figure 3 105: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 143
Figure 3 106: Comparison of Different Energy Sources During TUR-P 143
Figure 3 107: Effects of Flexible Ureteroscopy on Renal Blood Flow 144
Figure 3 108: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 144
Figure 3 109: Blue Light Cystoscopy With Cysview? Registry (BLCCR) 144
Figure 3 110: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 145
Figure 3 111: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 145
Figure 3 112: T-DOC? 5 Fr Pediatric Clinical Investigation 146
Figure 3 113: Air vs Water Catheters (AvW (Bonn)) 146
Figure 3 114: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 146
Figure 3 115: Portable Pves Study 147
Figure 3 116: Ambulatory Pessary Trial 147
Figure 3 117: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 148
Figure 3 118: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 148
Figure 3 119: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 149
Figure 3 120: Quality of Life in Kidney Stone Patients Undergoing Surgery 149
Figure 3 121: Prostate Vaporization Techniques in Canadian Hospital 150
Figure 3 122: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 150
Figure 3 123: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 151
Figure 3 124: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 151
Figure 3 125: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 151
Figure 3 126: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 152
Figure 4 1: Urological Device Market by Segment, U.S., 2015 – 2025 (US$M) (1 of 2) 155
Figure 4 2: Urological Device Market by Segment, U.S., 2015 – 2025 (US$M) (2 of 2) 156
Figure 4 3: Urological Device Market Growth by Segment, U.S., 2015 – 2025 (1 of 2) 161
Figure 4 4: Urological Device Market Growth by Segment, U.S., 2015 – 2025 (2 of 2) 162
Figure 4 5: Drivers and Limiters, Urological Device Market, U.S., 2018 165
Figure 4 6: Leading Competitors, Urological Device Market, U.S., 2018 (1 of 2) 168
Figure 4 7: Leading Competitors, Urological Device Market, U.S., 2018 (2 of 2) 169
Figure 4 8: SWOT Analysis, Boston Scientific, 2018 (1 of 2) 187
Figure 4 9: SWOT Analysis, Boston Scientific, 2018 (2 of 2) 188
Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 189
Figure 4 11: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 190
Figure 4 12: SWOT Analysis, Coloplast, 2018 191
Figure 4 13: SWOT Analysis, Cook Medical, 2018 (1 of 2) 192
Figure 4 14: SWOT Analysis, Cook Medical, 2018 (2 of 2) 193
Figure 4 15: SWOT Analysis, Elekta, 2018 194
Figure 4 16: SWOT Analysis, Ethicon, 2018 195
Figure 4 17: SWOT Analysis, Karl Storz, 2018 196
Figure 4 18: SWOT Analysis, Laborie, 2018 197
Figure 4 19: SWOT Analysis, Medline, 2018 (1 of 2) 198
Figure 4 20: SWOT Analysis, Medline, 2018 (2 of 2) 199
Figure 4 21: SWOT Analysis, Olympus, 2018 (1 of 2) 200
Figure 4 22: SWOT Analysis, Olympus, 2018 (2 of 2) 201
Figure 5 1: Procedure Codes Investigated, U.S., 2018 202
Figure 5 2: Urological Procedures by Type, U.S., 2015 – 2025 (1 of 2) 204
Figure 5 3: Urological Procedures by Type, U.S., 2015 – 2025 (2 of 2) 204
Figure 5 4: Urinary Incontinence Procedures by Type, U.S., 2015 – 2025 206
Figure 5 5: Male Incontinence Management Procedures by Type, U.S., 2015 – 2025 (1 of 2) 208
Figure 5 6: Female Incontinence Management Procedures by Type, U.S., 2015 – 2025 (1 of 2) 210
Figure 5 7: Female Incontinence Management Procedures by Type, U.S., 2015 – 2025 (2 of 2) 211
Figure 5 8: Stone Management Procedures by Type, U.S., 2015 – 2025 213
Figure 5 9: ESWL Procedures, U.S., 2015 – 2025 215
Figure 5 10: Transurethral Procedures by Type, U.S., 2015 – 2025 217
Figure 5 11: Ureteral Stent Placement Procedures, U.S., 2015 – 2025 219
Figure 5 12: PCNL Procedures, U.S., 2015 – 2025 221
Figure 5 13: BPH Patient Statistics, U.S., 2015 – 2025 223
Figure 5 14: BPH Procedures by Type, U.S., 2015 – 2025 (1 of 2) 225
Figure 5 15: BPH Procedures by Type, U.S., 2015 – 2025 (2 of 2) 226
Figure 5 16: Prostate Cancer Statistics, U.S., 2015 – 2025 228
Figure 5 17: Prostate Cancer Treatment Procedures by Type, U.S., 2015 – 2025 229
Figure 5 18: Watchful Waiting, U.S., 2015 – 2025 231
Figure 5 19: Prostatectomy Procedures by Approach, U.S., 2015 – 2025 (1 of 2) 233
Figure 5 20: Prostatectomy Procedures by Approach, U.S., 2015 – 2025 (2 of 2) 233
Figure 5 21: Open Prostatectomy Procedures by Approach, U.S., 2015 – 2025 (1 of 2) 235
Figure 5 22: Open Prostatectomy Procedures by Approach, U.S., 2015 – 2025 (2 of 2) 236
Figure 5 23: Prostate Ablation Procedures by Modality, U.S., 2015 – 2025 (1 of 2) 238
Figure 5 24: Prostate Ablation Procedures by Modality, U.S., 2015 – 2025 (2 of 2) 238
Figure 5 25: Radiation Therapy Procedures by Modality, U.S., 2015 – 2025 240
Figure 5 26: Prostate HDR Brachytherapy Procedures, U.S., 2015 – 2025 242
Figure 5 27: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2015 – 2025 (1 of 2) 244
Figure 5 28: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2015 – 2025 (2 of 2) 244
Figure 5 29: Prostate External Radiation Therapy Procedures by Modality, U.S., 2015 – 2025 246
Figure 5 30: Urodynamic Testing Procedures by Type, U.S., 2015 – 2025 248
Figure 5 31: Cystometrogram Procedures by Type, U.S., 2015 – 2025 250
Figure 5 32: Uroflowmetry Procedures by Type, U.S., 2015 – 2025 252
Figure 5 33: Nephrostomy Procedures by Type, U.S., 2015 – 2025 254
Figure 5 34: Erectile Dysfunction Management Procedures by Type, U.S., 2015 – 2025 256
Figure 6 1: Urinary Incontinence Device Market by Segment, U.S., 2015 – 2025 (US$M) 261
Figure 6 2: Urinary Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 265
Figure 6 3: Intermittent Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 267
Figure 6 4:Total Intermittent Catheter Market, U.S., 2015 – 2025 269
Figure 6 5: Coated Intermittent Catheter Market, U.S., 2015 – 2025 271
Figure 6 6: Uncoated Intermittent Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 273
Figure 6 7: Total Uncoated Intermittent Catheter Market, U.S., 2015 – 2025 275
Figure 6 8: Uncoated Latex-Free Intermittent Catheter Market, U.S., 2015 – 2025 277
Figure 6 9: Uncoated Latex Intermittent Catheter Market, U.S., 2015 – 2025 279
Figure 6 10: Closed System Intermittent Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 281
Figure 6 11: Total Closed System Intermittent Catheter Market, U.S., 2015 – 2025 283
Figure 6 12: Gel Closed System Intermittent Catheter Market, U.S., 2015 – 2025 285
Figure 6 13: Hydrophilic and Antimicrobial Closed System Intermittent Catheter Market, U.S., 2015 – 2025 287
Figure 6 14: Foley Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 289
Figure 6 15: Total Foley Catheter Market, U.S., 2015 – 2025 291
Figure 6 16: Coated Latex Foley Catheter Market, U.S., 2015 – 2025 293
Figure 6 17: Latex-Free Foley Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 295
Figure 6 18: Total Latex-Free Foley Catheter Market, U.S., 2015 – 2025 297
Figure 6 19: Uncoated Latex-Free Foley Catheter Market, U.S., 2015 – 2025 299
Figure 6 20: Coated Latex-Free Foley Catheter Market, U.S., 2015 – 2025 301
Figure 6 21: Closed System Foley Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 303
Figure 6 22: Total Closed System Foley Catheter Market, U.S., 2015 – 2025 305
Figure 6 23: Conventional Closed System Foley Catheter Market, U.S., 2015 – 2025 307
Figure 6 24: Antimicrobial Closed System Foley Catheter Market, U.S., 2015 – 2025 309
Figure 6 25: Male External Catheter Market, U.S., 2015 – 2025 311
Figure 6 26: Urethral Bulking Agent Market by Segment, U.S., 2015 – 2025 (US$M) 313
Figure 6 27: Total Urethral Bulking Agent Market, U.S., 2015 – 2025 315
Figure 6 28: Male Urethral Bulking Agent Market, U.S., 2015 – 2025 317
Figure 6 29: Female Urethral Bulking Agent Market, U.S., 2015 – 2025 319
Figure 6 30: Incontinence Management Device Market by Segment, U.S., 2015 – 2025 (US$M) 321
Figure 6 31: Female Incontinence Sling Market by Type, U.S., 2015 – 2025 (US$M) 324
Figure 6 32: Total Female Incontinence Sling Market, U.S., 2015 – 2025 326
Figure 6 33: Transvaginal Tape Female Incontinence Sling Market, U.S., 2015 – 2025 328
Figure 6 34: Transobturator Female Incontinence Sling Market, U.S., 2015 – 2025 330
Figure 6 35: Single-Incision Female Incontinence Sling Market, U.S., 2015 – 2025 332
Figure 6 36: Male Implantable Incontinence Device Market by Segment, U.S., 2015 – 2025 (US$M) 334
Figure 6 37: Male Incontinence Sling Market, U.S., 2015 – 2025 336
Figure 6 38: Male Artificial Urinary Sphincter Market, U.S., 2015 – 2025 338
Figure 6 39: Urinary Bag Market by Segment, U.S., 2015 – 2025 (US$M) 340
Figure 6 40: Total Urinary Bag Market, U.S., 2015 – 2025 342
Figure 6 41: Bedside Urine Drainage Bag Market, U.S., 2015 – 2025 344
Figure 6 42: Leg Urine Drainage Bag Market, U.S., 2015 – 2025 346
Figure 6 43: Drivers and Limiters, Urinary Incontinence Device Market, U.S., 2018 350
Figure 6 44: Leading Competitors, Urinary Incontinence Device Market, U.S., 2018 352
Figure 6 45: Leading Competitors, Urinary Catheter Market, U.S., 2018 354
Figure 6 46: Leading Competitors, Incontinence Management Device Market, U.S., 2018 356
Figure 6 47: Leading Competitors, Male Implantable Incontinence Device Market, U.S., 2018 358
Figure 7 1: Stone Management Device Market by Segment, U.S., 2015 – 2025 (US$M) 363
Figure 7 2: ESWL Equipment Market, U.S., 2015 – 2025 368
Figure 7 3: ISWL Equipment Market, U.S., 2015 – 2025 371
Figure 7 4: Holmium Laser Market by Segment, U.S., 2015 – 2025 (US$M) 373
Figure 7 5: Holmium Laser Equipment Market by Segment, U.S., 2015 – 2025 (US$M) 375
Figure 7 6: Total Holmium Laser Equipment Market, U.S., 2015 – 2025 377
Figure 7 7: High Power Holmium Laser Equipment Market, U.S., 2015 – 2025 379
Figure 7 8: Low Power Holmium Laser Equipment Market, U.S., 2015 – 2025 381
Figure 7 9: Holmium Laser Fiber Market by Segment, U.S., 2015 – 2025 (US$M) 384
Figure 7 10: Total Holmium Laser Fiber Market, U.S., 2015 – 2025 386
Figure 7 11: Reusable Holmium Laser Fiber Market, U.S., 2015 – 2025 388
Figure 7 12: Single-Use Holmium Laser Fiber Market, U.S., 2015 – 2025 390
Figure 7 13: Stone Fragment Retrieval Device Market by Segment, U.S., 2015 – 2025 (US$M) 393
Figure 7 14: Total Stone Fragment Retrieval Device Market, U.S., 2015 – 2025 395
Figure 7 15: Nitinol Stone Fragment Retrieval Device Market, U.S., 2015 – 2025 397
Figure 7 16: Stainless Steel Stone Fragment Retrieval Device Market, U.S., 2015 – 2025 399
Figure 7 17: Ureteral Stent Market, U.S., 2015 – 2025 402
Figure 7 18: Ureteral Stent Units by Type, U.S., 2018 404
Figure 7 19: Ureteral Stent Units by Material, U.S., 2018 406
Figure 7 20: Drivers and Limiters, Stone Management Device Market, U.S., 2018 410
Figure 7 21: Leading Competitors, Stone Management Device Market, U.S., 2018 415
Figure 8 1: BPH Treatment Device Market by Segment, U.S., 2015 – 2025 (US$M) 425
Figure 8 2: TURP Market by Segment, U.S., 2015 – 2025 (US$M) 429
Figure 8 3: Monopolar Electrode Market by Segment, U.S., 2015 – 2025 (US$M) 431
Figure 8 4: Total Monopolar Electrode Market, U.S., 2015 – 2025 433
Figure 8 5: Monopolar Electrode Loop Market, U.S., 2015 – 2025 435
Figure 8 6: Monopolar Coagulating Resector Electrode Market, U.S., 2015 – 2025 437
Figure 8 7: Monopolar Vaporizing Electrode Market, U.S., 2015 – 2025 439
Figure 8 8: Other Monopolar Electrode Device Market, U.S., 2015 – 2025 441
Figure 8 9: Bipolar Electrode Market by Segment, U.S., 2015 – 2025 (US$M) 443
Figure 8 10: Total Bipolar Electrode Market, U.S., 2015 – 2025 445
Figure 8 11: Bipolar Electrode Loop Market, U.S., 2015 – 2025 447
Figure 8 12: Bipolar Vaporizing Electrode Market, U.S., 2015 – 2025 449
Figure 8 13: Other Bipolar Electrode Device Market, U.S., 2015 – 2025 451
Figure 8 14: TUMT Market by Segment, U.S., 2015 – 2025 (US$M) 453
Figure 8 15: TUMT Equipment Market, U.S., 2015 – 2025 455
Figure 8 16: TUMT Consumables Market, U.S., 2015 – 2025 457
Figure 8 17: TUNA Market by Segment, U.S., 2015 – 2025 (US$M) 459
Figure 8 18: TUNA Equipment Market, U.S., 2015 – 2025 461
Figure 8 19: TUNA Consumables Market, U.S., 2015 – 2025 463
Figure 8 20: Prostatic Stent Market by Segment, U.S., 2015 – 2025 (US$M) 465
Figure 8 21: Total Prostatic Stent Market, U.S., 2015 – 2025 467
Figure 8 22: Permanent Prostatic Stent Market, U.S., 2015 – 2025 469
Figure 8 23: Temporary Prostatic Stent Market, U.S., 2015 – 2025 471
Figure 8 24: Laser BPH Market by Segment, U.S., 2015 – 2025 (US$M) 473
Figure 8 25: Laser BPH Equipment Market, U.S., 2015 – 2025 475
Figure 8 26: Laser BPH Fiber Market by Segment, U.S., 2015 – 2025 (US$M) 478
Figure 8 27: Total Laser BPH Fiber Market, U.S., 2015 – 2025 480
Figure 8 28: PVP Laser Fiber Market, U.S., 2015 – 2025 482
Figure 8 29: Laser Enucleation Fiber Market, U.S., 2015 – 2025 484
Figure 8 30: Other Laser BPH Fiber Market, U.S., 2015 – 2025 486
Figure 8 31: UroLift Market, U.S., 2015 – 2025 488
Figure 8 32: Rez?m Market, U.S., 2015 – 2025 490
Figure 8 33: Drivers and Limiters, BPH Treatment Device Market, U.S., 2018 495
Figure 8 34: Leading Competitors, BPH Treatment Device Market, U.S., 2018 498
Figure 8 35: Leading Competitors, TURP Market, U.S., 2018 500
Figure 9 1: Urological Endoscope Market by Segment, U.S., 2015 – 2025 (US$M) 505
Figure 9 2: Urological Endoscope Market by Condition, U.S., 2015 – 2025 (US$M) 509
Figure 9 3: Total Urological Endoscope Market, U.S., 2015 – 2025 514
Figure 9 4: Cystoscope Market by Segment, U.S., 2015 – 2025 (US$M) 516
Figure 9 5: Total Cystoscope Market, U.S., 2015 – 2025 518
Figure 9 6: Rigid Cystoscope Market by Condition, U.S., 2015 – 2025 (US$M) 521
Figure 9 7: Total Rigid Cystoscope Market, U.S., 2015 – 2025 523
Figure 9 8: New Rigid Cystoscope Market, U.S., 2015 – 2025 525
Figure 9 9: Refurbished Rigid Cystoscope Market, U.S., 2015 – 2025 527
Figure 9 10: Flexible Cystoscope Market by Condition, U.S., 2015 – 2025 (US$M) 529
Figure 9 11: Total Flexible Cystoscope Market, U.S., 2015 – 2025 531
Figure 9 12: New Flexible Cystoscope Market by Type, U.S., 2015 – 2025 (US$M) 534
Figure 9 13: Total New Flexible Cystoscope Market, U.S., 2015 – 2025 536
Figure 9 14: New Flexible Fiber Cystoscope Market, U.S., 2015 – 2025 538
Figure 9 15: New Flexible Video Cystoscope Market, U.S., 2015 – 2025 540
Figure 9 16: Refurbished Flexible Cystoscope Market by Type, U.S., 2015 – 2025 (US$M) 542
Figure 9 17: Total Refurbished Flexible Cystoscope Market, U.S., 2015 – 2025 544
Figure 9 18: Refurbished Flexible Fiber Cystoscope Market, U.S., 2015 – 2025 546
Figure 9 19: Refurbished Flexible Video Cystoscope Market, U.S., 2015 – 2025 548
Figure 9 20: Ureteroscope Market by Segment, U.S., 2015 – 2025 (US$M) 550
Figure 9 21: Total Ureteroscope Market, U.S., 2015 – 2025 552
Figure 9 22: Semi-Rigid Ureteroscope Market by Condition, U.S., 2015 – 2025 (US$M) 555
Figure 9 23: Total Semi-Rigid Ureteroscope Market, U.S., 2015 – 2025 557
Figure 9 24: New Semi-Rigid Ureteroscope Market, U.S., 2015 – 2025 559
Figure 9 25: Refurbished Semi-Rigid Ureteroscope Market, U.S., 2015 – 2025 561
Figure 9 26: Flexible Ureteroscope Market by Condition, U.S., 2015 – 2025 (US$M) 563
Figure 9 27: Total Flexible Ureteroscope Market, U.S., 2015 – 2025 565
Figure 9 28: New Flexible Ureteroscope Market by Segment, U.S., 2015 – 2025 (US$M) 567
Figure 9 29: Total New Flexible Ureteroscope Market, U.S., 2015 – 2025 569
Figure 9 30: New Flexible Fiber Ureteroscope Market, U.S., 2015 – 2025 571
Figure 9 31: New Flexible Video Ureteroscope Market, U.S., 2015 – 2025 573
Figure 9 32: New Single-Use Flexible Video Ureteroscope Market, U.S., 2015 – 2025 575
Figure 9 33: Refurbished Flexible Ureteroscope Market by Type, U.S., 2015 – 2025 (US$M) 577
Figure 9 34: Total Refurbished Flexible Ureteroscope Market, U.S., 2015 – 2025 579
Figure 9 35: Refurbished Flexible Fiber Ureteroscope Market, U.S., 2015 – 2025 581
Figure 9 36: Refurbished Flexible Video Ureteroscope Market, U.S., 2015 – 2025 583
Figure 9 37: Resectoscope Market by Condition, U.S., 2015 – 2025 (US$M) 585
Figure 9 38: Total Resectoscope Market, U.S., 2015 – 2025 587
Figure 9 39: New Resectoscope Market, U.S., 2015 – 2025 589
Figure 9 40: Refurbished Resectoscope Market, U.S., 2015 – 2025 591
Figure 9 41: Nephroscope Market by Condition, U.S., 2015 – 2025 (US$M) 593
Figure 9 42: Total Nephroscope Market, U.S., 2015 – 2025 595
Figure 9 43: New Nephroscope Market, U.S., 2015 – 2025 597
Figure 9 44: Refurbished Nephroscope Market, U.S., 2015 – 2025 599
Figure 9 45: Drivers and Limiters, Urological Endoscope Market, U.S., 2018 603
Figure 9 46: Leading Competitors, Urological Endoscope Market, U.S., 2018 606
Figure 9 47: Leading Competitors, Cystoscope Market, U.S., 2018 608
Figure 9 48: Leading Competitors, Ureteroscope Market, U.S., 2018 610
Figure 9 49: Leading Competitors, Flexible Ureteroscope Market, U.S., 2018 612
Figure 10 1: Prostate Cancer Treatment Device Market by Segment, U.S., 2015 – 2025 (US$M) 616
Figure 10 2: Brachytherapy Device Market by Segment, U.S., 2015 – 2025 (US$M) 620
Figure 10 3: HDR Brachytherapy Market by Segment, U.S., 2015 – 2025 (US$M) 622
Figure 10 4: Afterloader Market, U.S., 2015 – 2025 624
Figure 10 5: Afterloader Service Market, U.S., 2015 – 2025 626
Figure 10 6: LDR Brachytherapy Market by Segment, U.S., 2015 – 2025 (US$M) 628
Figure 10 7: LDR Seed Market by Isotope, U.S., 2015 – 2025 (US$M) 630
Figure 10 8: LDR Seed Market by Seed Type, U.S., 2015 – 2025 (US$M) 632
Figure 10 9: Total LDR Seed Market, U.S., 2015 – 2025 634
Figure 10 10: Cs-131 Market by Seed Type, U.S., 2015 – 2025 (US$M) 636
Figure 10 11: Total Cs-131 Market, U.S., 2015 – 2025 638
Figure 10 12: Stranded Cs-131 Market, U.S., 2015 – 2025 640
Figure 10 13: Non-Stranded Cs-131 Market, U.S., 2015 – 2025 642
Figure 10 14: Pd-103 Market by Seed Type, U.S., 2015 – 2025 (US$M) 644
Figure 10 15: Total Pd-103 Market, U.S., 2015 – 2025 646
Figure 10 16: Stranded Pd-103 Market, U.S., 2015 – 2025 648
Figure 10 17: Non-Stranded Pd-103 Market, U.S., 2015 – 2025 650
Figure 10 18: I-125 Market by Seed Type, U.S., 2015 – 2025 (US$M) 652
Figure 10 19: Total I-125 Market, U.S., 2015 – 2025 654
Figure 10 20: Stranded I-125 Market, U.S., 2015 – 2025 656
Figure 10 21: Non-Stranded I-125 Market, U.S., 2015 – 2025 658
Figure 10 22: LDR Needle Market, U.S., 2015 – 2025 660
Figure 10 23: Cryotherapy Ablation Device Market by Segment, U.S., 2015 – 2025 (US$M) 663
Figure 10 24: Cryotherapy Ablation Device Market, U.S., 2015 – 2025 665
Figure 10 25: Cryotherapy Ablation Device Rental Market, U.S., 2015 – 2025 667
Figure 10 26: Cryotherapy Ablation Probe Market, U.S., 2015 – 2025 669
Figure 10 27: Drivers and Limiters, Prostate Cancer Treatment Device Market, U.S., 2018 672
Figure 10 28: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2018 675
Figure 10 29: Leading Competitors, Brachytherapy Device Market, U.S., 2018 677
Figure 11 1: Urodynamic Equipment Market by Segment, U.S., 2015 – 2025 (US$M) 681
Figure 11 2: Urodynamic Equipment Market by Segment, U.S., 2015 – 2025 (US$M) 685
Figure 11 3: Total Urodynamic Equipment Market, U.S., 2015 – 2025 687
Figure 11 4: Hospital Urodynamic Capital Equipment Market, U.S., 2015 – 2025 690
Figure 11 5: Medical Office Urodynamic Capital Equipment Market, U.S., 2015 – 2025 692
Figure 11 6: Urodynamic Consumables Market by Segment, U.S., 2015 – 2025 (US$M) 694
Figure 11 7: Total Urodynamic Consumables Market, U.S., 2015 – 2025 696
Figure 11 8: Air-Charged Catheter Market, U.S., 2015 – 2025 699
Figure 11 9: Water-Filled Catheter Market, U.S., 2015 – 2025 702
Figure 11 10: Fiber Optic Catheter Market, U.S., 2015 – 2025 705
Figure 11 11: Drivers and Limiters, Urodynamic Equipment Market, U.S., 2018 708
Figure 11 12: Leading Competitors, Urodynamic Equipment Market, U.S., 2018 711
Figure 12 1: Nephrostomy Devic